• Post-Cyclophosphamide for GVHD prophylaxis (D. Blaise, France)
• The thiotepa-based platform for refractory malignancies (R. Dulery, France)
• The novel treosulfan-based platform for conditioning (Arnon Nagler, Israel)
• Round table discussion
Moderators: Mohamad Mohty and Arnon Nagler
November 15, 2021
Ещё видео!